Solvias

Activities: Manufacturing Research & Development

Solvias is a worldwide leader in contract research, development and manufacturing for the pharmaceutical, biotech, material science and cosmetic industries. Drawing on 20 years of scientific excellence, the company provides flexible and scalable analytical and manufacturing solutions that ensure the integrity of pharmaceutical and medical device products across their life cycle. Headquartered in Kaiseraugst near Basel, Switzerland, Solvias and its laboratories operate to the highest standards and in accordance with ISO, GMP, GLP and FDA regulations.

Trending Articles

  1. Wacker Biotech to manufacture protein ingredients for MinervaX's late-stage GBS vaccine The vaccine is currently being prepared for Phase III trials, and aims to protect mothers and their babies from group B streptococcus infections
  2. Novartis' Kisqali plus ET bags FDA approval for HR+/HER2- breast cancer The decision comes off the back of the Phase III NATALEE clinical trial, which diminished the risk of disease recurrence by 25.1%
  3. AstraZeneca opens a 'people hub' at its Macclesfield site The energy-efficient building will offer AZ employees a collaborative space
  4. Ensuring cGMP compliance in cell and gene therapy manufacturing 3P discusses how companies can scale up their CGT manufacturing protocols while remaining compliant with stringent global regulations
  5. Piramal Pharma's sustainability goals get SBTi-validated The company wants to reduce its scope 1 and 2 GHG emissions by 42% by 2030, and is also working on developing a carbon reduction plan

Upcoming event

Boston Biotech Week

23-26 September, 2024 | Convention and exhibition | Boston, US See all

Related Content

Manufacturing

Did you know? USP compliance is expected by 2026

Ensuring compliance and safety in single-use manufacturing
Manufacturing

Solvias to build Biologics and Cell & Gene Therapy testing centre in Research Triangle Park

Global provider continues to expand analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases
Manufacturing

Solvias to perform release testing on world’s first CRISPR-based gene-editing therapy

Global provider signs long-term agreement with Vertex Pharmaceuticals for CASGEVY (trademarked)
Manufacturing

Solvias acquires Cergentis to boost biologics testing capabilities

The pharma testing company has made the acquisition to supports the increasing number of global pharmaceutical, biotech, and contract development and manufacturing organisations developing genetically engineered therapies
Analysis

Merck announces collaboration with Solvias

The partnership will offer the PyroMAT System, a new MAT kit for pyrogen detection

Solvias broadens QC offering

New department will cover full range of customer needs in the pharma industry
Manufacturing

Hovione and Solvias announce a collaboration to improve drug solubility

Combines the strengths of each company
Subscribe now